Given the BCL2 family PPIs and their association with cancer pathways, we speculated that the transcriptional signatures reflecting the complicated regulatory networks of the BCL2 family exist and may guide individualized treatment strategies targeting the BCL2 family. Here, BCL2 is linked to cancer.